This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shariat, S. F. Articles by Lerner, S. P. Search for Related Content Social Bookmarking                         What's this?

Review: Use of nomograms for predictions of outcome in patients with advanced bladder cancer

Division of Urology; Sidney Kimmel Center for Prostate and Urologic Cancer, Memorial Sloan-Kettering Cancer Center, New York, USA

Pierre I. Karakiewicz

Cancer Prognostics and Health Outcomes Unit, University of Montreal, Health Center, (CHUM) Montreal, QC, Canada

Guilherme Godoy

Division of Urology; Sidney Kimmel Center for Prostate and Urologic Cancer, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 27, New York, NY 10065, USA

Seth P. Lerner

Urology, Beth and Dave Swalm Chair of Urologic Oncology, Scott Department of Urology, Baylor College of Medicine, 6620 Main Suite 1325, Houston, Texas 77030, USA, slerner{at}bcm.edu

Introduction: Accurate estimates of risk are essential for physicians if they are to recommend a specific management to patients with bladder cancer. In this review, we discuss the criteria for the evaluation of nomograms and review current available nomograms for advanced bladder cancer.

Methods: A retrospective review of the Pubmed database between 2002 and 2008 was performed using the keywords `nomogram' and `bladder'. We limited the articles to advanced bladder cancer. We recorded input variables, prediction form, number of patients used to develop the prediction tools, the outcome being predicted, prediction tool-specific features, predictive accuracy, and whether validation was performed.

Results: We discuss the characteristics needed to evaluate nomograms such as predictive accuracy, calibration, generalizability, level of complexity, effect of competing risks, conditional probabilities, and head-to-head comparison with other prediction methods. The predictive accuracies of the pre-cystectomy tools (n = 2) range from ~65—75% and that of the post-cystectomy tools (n = 5) range from ~75—80%. While some of these nomograms are well-calibrated and outperform AJCC staging, none has been externally validated. To date, four studies demonstrated a statistically significant improvement in predictive accuracy of nomograms by including biomarkers.

Conclusions: Nomograms provide accurate individualized estimates of outcomes. They currently represent the most accurate and discriminatory decision-making aids tools for predicting outcomes in patients with bladder cancer. Use of current nomograms could improve current selection of patients for standard therapy and investigational trial design by ensuring homogeneous groups. The addition of biological markers to the currently available nomograms using clinical and pathologic data holds the promise of improving prediction and refining management of patients with bladder cancer.

Key Words: bladder cancer • nomogram • prediction • prognosis • risk

Therapeutic Advances in Urology, Vol. 1, No. 1, 13-26 (2009)
DOI: 10.1177/1756287209103923


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?